4//SEC Filing
Chen Jing 4
Accession 0001104659-22-076931
CIK 0001563665other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 5:50 PM ET
Size
8.1 KB
Accession
0001104659-22-076931
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
Chen Jing
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-29+6,241→ 6,241 totalExercise: $4.65Exp: 2032-06-29→ Common Stock, par value $0.01 per share (6,241 underlying) - Award
Stock Option (right to buy)
2022-06-29+5,016→ 5,016 totalExercise: $4.65Exp: 2032-06-29→ Common Stock, par value $0.01 per share (5.016 underlying)
Footnotes (2)
- [F1]This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 29, 2022, December 29, 2022, March 29, 2023 and June 29, 2023.
- [F2]This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2022, September 30, 2022 and December 31, 2022.
Documents
Issuer
Biostage, Inc.
CIK 0001563665
Entity typeother
Related Parties
1- filerCIK 0001727177
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 5:50 PM ET
- Size
- 8.1 KB